Rapid Evidence Production Service to Support Health Decision Making– Experience of the Brazilian Ministry of Health

Session Type
Rapid reviews and other rapid evidence products
Wachira V1, Batista J1, Toledo I1, Andrade K1, Silva R1, Serpa F1, Marinho M1, Rêgo D1
1Department of Science and Technology, Ministry of Health Brazil, Brazil

Background: The Department of Science and Technology of the Ministry of Health (MoH) is responsible for stimulating scientific health research in Brazil by directing the financial resources of the Federal Government to public health needs. The Department also promotes the systematic use of scientific evidence to support the implementation and improvement of health policies by decision-makers of the Unified Health System (SUS). Thus, the Evidence Center (NEv), of the General Coordination of Evidence in Health was established. It’s main objective is to produce rapid evidence synthesis products to aid decision making within the MoH.
Objectives: To describe the experience of NEv in the rapid evidence production to support decision-making in the Brazilian MoH.
Methods: In 2019, NEv was established and the service was launched comprising two modalities of evidence production: an internal one, in which NEv team conducts the studies; and an external one, where NEv articulates contracts with external researchers. The type of evidence synthesis products to be elaborated depends on the decision-makers research question, the availability of evidence and the time required for the response, according to the Product Portfolio that guides this service. The whole process is carried out in an active participatory manner in collaboration with the technical area requesting the evidence synthesis.
Results: Between 2019 and 2022, NEv produced 235 studies to meet the demands of the technical areas of the MoH, 34 in 2019, 101 in 2020, 61 in 2021, and 39 in 2022. Some of the evidence syntheses were produced by external partners, such as renowned Research Centers and Universities within the scope of the contract agreement; healthcare hospitals of recognized excellence by SUS in the context of the Support Program for Institutional Development of the Unified Health System and some were produced through research public calls. Between 2020 and 2022, 87 of the studies produced were in the context of the Covid-19 pandemic, bringing NEv to the limelight as one of the main actors inside the MoH in supporting evidence-informed decision-making.
Conclusions: This initiative has been aiding decision-making in many areas of the MoH.
Patient, public and/or healthcare consumer involvement: MoH